𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children

✍ Scribed by H. Scholz; R. Noack


Publisher
Springer
Year
1998
Tongue
English
Weight
987 KB
Volume
17
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Double-blind multicenter comparison of c
✍ Steve Seifert πŸ“‚ Article πŸ“… 1983 πŸ› Elsevier Science 🌐 English βš– 125 KB

warmings were accomplished. The methods were warm air inhalation, trunk immersion, heating pads, plumbed garments, passive rewarming, body-to-body heat transfers, and combinations of inhalation/heating pads and inhalation/ plumbed garments. The parameters examined were "after drop," "recovery time"

A randomized double-blind controlled tri
✍ Paul Hong; Neil Smith; Liane B. Johnson; Gerard Corsten πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 103 KB

## Abstract ## Objective: To compare the postoperative complication rates of phosphorylcholine‐coated fluoroplastic tympanostomy tubes versus uncoated fluoroplastic tympanostomy tubes. ## Methods: A prospective randomized double‐blind controlled trial in children with recurrent acute otitis medi

Randomized controlled trial of desmopres
✍ Dr. Roberto de Franchis; Paolo G. Arcidiacono; Luca Carpinelli; Bruno Andreoni; πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 702 KB

l-Deamino-8-D-arginine vasopressin (DDAVP, desmopressin), a synthetic analog of the antidiuretic hormone L-arginine vasopressin, improves hemostasis parameters in cirrhotic patients. Hence its use in combination with a vasoactive drug such as terlipressin might improve the performance of this drug i

Efficacy and safety of a once-yearly i.v
✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; πŸ“‚ Article πŸ“… 2010 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi